Skip to main content

Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects with Epileptic Encephalopathy with Continuous Spike-and-Wav

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neurology

Awarded By

Neurocrine Biosciences, Inc.

Start Date

November 19, 2021

End Date

October 31, 2023
 

Administered By

Pediatrics, Neurology

Awarded By

Neurocrine Biosciences, Inc.

Start Date

November 19, 2021

End Date

October 31, 2023